Priming Leukemia with 5-Azacytidine Enhances CAR T Cell Therapy.

Xu, Ning; Tse, Benjamin; Yang, Lu; Tang, Tiffany C Y; Haber, Michelle; Micklethwaite, Kenneth; Dolnikov, Alla

Xu, Ning; Tse, Benjamin; Yang, Lu; Tang, Tiffany C Y; Haber, Michelle; Micklethwaite, Kenneth; Dolnikov, Alla.

Afiliación

Xu N; Children's Cancer Institute, University of New South Wales, Sydney, NSW, Australia.
Tse B; School of Women's and Children's Health, University of New South Wales, Sydney, NSW, Australia.
Yang L; Children's Cancer Institute, University of New South Wales, Sydney, NSW, Australia.
Tang TCY; School of Women's and Children's Health, University of New South Wales, Sydney, NSW, Australia.
Haber M; Children's Cancer Institute, University of New South Wales, Sydney, NSW, Australia.
Micklethwaite K; School of Women's and Children's Health, University of New South Wales, Sydney, NSW, Australia.
Dolnikov A; Children's Cancer Institute, University of New South Wales, Sydney, NSW, Australia.

Immunotargets Ther ; 10: 123-140, 2021.

Article en En | MEDLINE | ID: mdl-33954150

Palabras clave

AZA; CAR T cells; gene expression; leukemia; patient-derived xenografts

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Immunotargets Ther Año: 2021 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Nueva Zelanda

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google